Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Clin Pharmacol Ther. 2021 Aug 23;111(1):218–226. doi: 10.1002/cpt.2377

Figure 1.

Figure 1.

Identification of study samples

Object drug-specific study samples were constructed separately. Object drugs (glimepiride, glipizide, glyburide, nateglinide, repaglinide, and metformin) are indicated in the parentheses.